Clinical Trial Update: Low Dose Primaquine for Clearance of Gametocytes [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/Phase 3 trial evaluating low-dose primaquine to clear gametocytes in malaria has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria
• Plasmodium Falciparum Malaria

Drugs mentioned

• Primaquine (low-dose) (primaquine)

Snippet

Sponsor: London School of Hygiene and Tropical Medicine | Conditions: Malaria, Asymptomatic Malaria | Phase 2, Phase 3 | Status: COMPLETED